Functional characterization of the atypical member of the IkappaB inhibitor Bcl-3 in pancreatic ductal adenocarcinoma (P04)
Functional characterization of the atypical member of the IkappaB inhibitor Bcl-3 in pancreatic ductal adenocarcinoma (P04)
批准号:
403605915
负责人:
金额:
$0.0万
依托单位国家:
德国
项目类别:
Collaborative Research Centres
财政年份:
2018
资助国家:
德国
项目状态:
已结题
起止时间:
2017-12-31 至 2021-12-31
中文摘要
蛋白质B细胞CLL/淋巴瘤3(Bcl-3)的kappa-B(IkappaB)家族的抑制剂的非典型成员是血液恶性肿瘤中确定的癌基因。在这里,我们首次证明了Bcl-3在人类和小鼠PDAC中的过度磷酸化。使用各种遗传工具,我们报告,过度磷酸化Bcl-3负调控胰腺癌的发生和转移。我们将详细阐述Bcl-3及其磷酸化位点在PDAC中以前未被认识的作用,并强调Bcl-3在这种疾病中的新方面。
英文摘要
The atypical member of the Inhibitor of kappa-B (IkappaB) family of proteins B-cell CLL/lymphoma 3 (Bcl-3) is an established oncogene in hematologic malignancies. Here we demonstrate for the first-time hyperphosphorylation of Bcl-3 in human and murine PDAC. Using various genetic tools we report that hyperphosphorylated Bcl-3 negatively regulates pancreatic carcinogenesis and metastasis. We will elaborate the previously unrecognized role for Bcl-3 and its phosphorylated sites in PDAC and highlight new aspects of Bcl-3 in this disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金